Joint analysis of longitudinal and survival AIDS data with a spatial fraction of long‐term survivors: A Bayesian approach

A typical survival analysis with time-dependent covariates usually does not take into account the possible random fluctuations or the contamination by measurement errors of the variables. Ignoring these sources of randomness may cause bias in the estimates of the model parameters. One possible way for overcoming that limitation is to consider a longitudinal model for the time-varying covariates jointly with a survival model for the time to the event of interest, thereby taking advantage of the complementary information flowing between these two-model outcomes. We employ here a Bayesian hierarchical approach to jointly model spatial-clustered survival data with a fraction of long-term survivors along with the repeated measurements of CD4+ T lymphocyte counts for a random sample of 500 HIV/AIDS individuals collected in all the 27 states of Brazil during the period 2002-2006. The proposed Bayesian joint model comprises two parts: on the one hand, a flexible model using Penalized Splines to better capture the nonlinear behavior of the different CD4 profiles over time; on the other hand, a spatial cure model to cope with the set of long-term survivor individuals. Our findings show that joint models considering this set of patients were the ones with the best performance comparatively to the more traditional survival approach. Moreover, the use of spatial frailties allowed us to map the heterogeneity in the disease risk among the Brazilian states.

[1]  Rajeshwari Sundaram,et al.  A Joint Mixed Effects Dispersion Model for Menstrual Cycle Length and Time‐to‐Pregnancy , 2012, Biometrics.

[2]  Paul H. C. Eilers,et al.  Flexible smoothing with B-splines and penalties , 1996 .

[3]  Andreas Brezger,et al.  Generalized structured additive regression based on Bayesian P-splines , 2006, Comput. Stat. Data Anal..

[4]  M. Wulfsohn,et al.  A joint model for survival and longitudinal data measured with error. , 1997, Biometrics.

[5]  Cécile Proust-Lima,et al.  Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach. , 2009, Biostatistics.

[6]  Joseph G Ibrahim,et al.  Bayesian Approaches to Joint Cure‐Rate and Longitudinal Models with Applications to Cancer Vaccine Trials , 2003, Biometrics.

[7]  Marilia Sá Carvalho,et al.  Accuracy of a probabilistic record linkage strategy applied to identify deaths among cases reported to the Brazilian AIDS surveillance database. , 2010, Cadernos de saude publica.

[8]  G Wan A simple stochastic model of AIDSepidemic , 2003 .

[9]  Joseph Berkson,et al.  Survival Curve for Cancer Patients Following Treatment , 1952 .

[10]  Bradley P Carlin,et al.  Flexible Cure Rate Modeling Under Latent Activation Schemes , 2007, Journal of the American Statistical Association.

[11]  Simon Jackman,et al.  Wiley Series in Probability and Statistics , 2009 .

[12]  S. Lang,et al.  Bayesian P-Splines , 2004 .

[13]  J G Ibrahim,et al.  The Large Sample Distribution of the Weighted Log Rank Statistic Under General Local Alternatives , 1997, Lifetime data analysis.

[14]  Myles Cockburn,et al.  Population-based linkage of AIDS and cancer registries: importance of linkage algorithm. , 2007, American journal of preventive medicine.

[15]  R. Temple,et al.  Are surrogate markers adequate to assess cardiovascular disease drugs? , 1999, JAMA.

[16]  Joseph G. Ibrahim,et al.  A New Bayesian Model For Survival Data With a Surviving Fraction , 1999 .

[17]  J. Griffin,et al.  Bayesian adaptive lassos with non-convex penalization , 2007 .

[18]  Eleni-Rosalina Andrinopoulou,et al.  Combined dynamic predictions using joint models of two longitudinal outcomes and competing risk data , 2017, Statistical methods in medical research.

[19]  Paul H. C. Eilers,et al.  Splines, knots, and penalties , 2010 .

[20]  S. Geisser,et al.  A Predictive Approach to Model Selection , 1979 .

[21]  Jammbe Z Musoro,et al.  A joint model for repeated events of different types and multiple longitudinal outcomes with application to a follow‐up study of patients after kidney transplant , 2015, Biometrical journal. Biometrische Zeitschrift.

[22]  Nadja Klein,et al.  Scale-Dependent Priors for Variance Parameters in Structured Additive Distributional Regression , 2016 .

[23]  Peter Müller,et al.  A Bayesian Semiparametric Survival Model with Longitudinal Markers , 2010, Biometrics.

[24]  Kholoud Porter,et al.  Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy , 2014, AIDS.

[25]  Yanchun Bao,et al.  Joint longitudinal and survival‐cure models in tumour xenograft experiments , 2014, Statistics in medicine.

[26]  Rui Martins,et al.  Joint analysis of longitudinal and survival AIDS data - a Bayesian perspective , 2014 .

[27]  A A Tsiatis,et al.  A linear rank test for use when the main interest is in differences in cure rates. , 1989, Biometrics.

[28]  Dimitris Rizopoulos,et al.  Dynamic Predictions and Prospective Accuracy in Joint Models for Longitudinal and Time‐to‐Event Data , 2011, Biometrics.

[29]  Menggang Yu,et al.  JOINT LONGITUDINAL-SURVIVAL-CURE MODELS AND THEIR APPLICATION TO PROSTATE CANCER , 2004 .

[30]  Vernon T. Farewell,et al.  Mixture models in survival analysis: Are they worth the risk? , 1986 .

[31]  Sumio Watanabe,et al.  Asymptotic Equivalence of Bayes Cross Validation and Widely Applicable Information Criterion in Singular Learning Theory , 2010, J. Mach. Learn. Res..

[32]  Andrew N. Phillips,et al.  Projected life expectancy of people with HIV according to timing of diagnosis , 2012, AIDS.

[33]  D. Thomas,et al.  Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach. , 1996, Statistics in medicine.

[34]  Ming-Hui Chen,et al.  A new threshold regression model for survival data with a cure fraction , 2011, Lifetime data analysis.

[35]  A. Gelman Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper) , 2004 .

[36]  Myles Cockburn,et al.  Population-Based Linkage of AIDS and Cancer Registries of Linkage Algorithm , 2007 .

[37]  A Tsodikov,et al.  Modeling carcinogenesis under a time-changing exposure. , 1998, Mathematical biosciences.

[38]  Sudipto Banerjee,et al.  Modelling geographically referenced survival data with a cure fraction , 2006, Statistical methods in medical research.

[39]  J. Besag,et al.  Bayesian image restoration, with two applications in spatial statistics , 1991 .

[40]  James J. Goedert,et al.  Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada , 2013, PloS one.

[41]  Simon G Thompson,et al.  Joint modelling of longitudinal and time-to-event data with application to predicting abdominal aortic aneurysm growth and rupture , 2011, Biometrical journal. Biometrische Zeitschrift.

[42]  Rui Martins,et al.  Bayesian joint modeling of longitudinal and spatial survival AIDS data , 2016, Statistics in medicine.

[43]  V. Farewell,et al.  The use of mixture models for the analysis of survival data with long-term survivors. , 1982, Biometrics.

[44]  Dimitris Rizopoulos,et al.  A Bayesian semiparametric multivariate joint model for multiple longitudinal outcomes and a time‐to‐event , 2011, Statistics in medicine.

[45]  C. Szwarcwald,et al.  Delay in introducing antiretroviral therapy in patients infected by HIV in Brazil, 2003-2006. , 2007, Clinics.

[46]  J. Ibrahim,et al.  A Flexible B‐Spline Model for Multiple Longitudinal Biomarkers and Survival , 2005, Biometrics.

[47]  Sw. Banerjee,et al.  Hierarchical Modeling and Analysis for Spatial Data , 2003 .

[48]  Andrew Thomas,et al.  WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..

[49]  Sudipto Banerjee,et al.  Analysis of cure rate survival data under proportional odds model , 2011, Lifetime data analysis.

[50]  Kathy Petoumenos,et al.  Long-Term Survival in HIV Positive Patients with up to 15 Years of Antiretroviral Therapy , 2012, PloS one.

[51]  A. Gelfand,et al.  Bayesian Model Choice: Asymptotics and Exact Calculations , 1994 .

[52]  Peter Reiss,et al.  Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals , 2010, AIDS.

[53]  Joseph G. Ibrahim,et al.  A new joint model for longitudinal and survival data with a cure fraction , 2004 .

[54]  Rolando De la Cruz Bayesian ideas and data analysis: An introduction for scientists and statisticians , 2012 .

[55]  R. Écochard,et al.  Application of the promotion time cure model with time‐changing exposure to the study of HIV/AIDS and other infectious diseases , 2007, Statistics in medicine.

[56]  Calyampudi R. Rao,et al.  Linear statistical inference and its applications , 1965 .

[57]  J B Greenhouse,et al.  Assessing Placebo Response Using Bayesian Hierarchical Survival Models , 1998, Lifetime data analysis.